Protagenic Therapeutics raises $1.275M in private placement of common stock and warrants

Protagenic Therapeutics, Inc.new

Issued 1,948,295 shares (or pre-funded warrants) at $0.64 per share ($0.89 for insiders).
Also issued Series A warrants (18-month term) and Series B warrants (5-year term), both exercisable at $0.64.
Gross proceeds ~$1.275 million; net proceeds for working capital.
Closing expected on or before November 4, 2024; Brookline Capital Markets acted as placement agent.
Directors and officers subject to 90-day lock-up from closing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.